These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35286974)

  • 41. Vigabatrin for partial-onset seizure treatment in patients with tuberous sclerosis complex.
    Friedman D; Bogner M; Parker-Menzer K; Devinsky O
    Epilepsy Behav; 2013 Apr; 27(1):118-20. PubMed ID: 23399947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety of inactivated COVID-19 vaccine in tuberous sclerosis complex patients with epilepsy treated with rapamycin.
    Lu Q; Wang YY; Wang QH; Tang LN; Yang XY; Dun S; Zou LP
    Seizure; 2022 Jul; 99():71-74. PubMed ID: 35605444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Scalp EEG spikes predict impending epilepsy in TSC infants: A longitudinal observational study.
    Wu JY; Goyal M; Peters JM; Krueger D; Sahin M; Northrup H; Au KS; O'Kelley S; Williams M; Pearson DA; Hanson E; Byars AW; Krefting J; Beasley M; Cutter G; Limdi N; Bebin EM
    Epilepsia; 2019 Dec; 60(12):2428-2436. PubMed ID: 31691264
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Follow-up of tuberous sclerosis complex complicated by epilepsy in children].
    Wen JL; Liao JX; Chen L; Hu Y; Li B; Huang TS; Lu XG; Wang XJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Dec; 11(12):996-8. PubMed ID: 20113608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study.
    Ebrahimi-Fakhari D; Mann LL; Poryo M; Graf N; von Kries R; Heinrich B; Ebrahimi-Fakhari D; Flotats-Bastardas M; Gortner L; Zemlin M; Meyer S
    Orphanet J Rare Dis; 2018 Jul; 13(1):117. PubMed ID: 30016967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epileptic spasms are associated with increased stereo-electroencephalography derived functional connectivity in tuberous sclerosis complex.
    Neal A; Bouet R; Lagarde S; Ostrowsky-Coste K; Maillard L; Kahane P; Touraine R; Catenoix H; Montavont A; Isnard J; Arzimanoglou A; Hermier M; Guenot M; Bartolomei F; Rheims S; Jung J
    Epilepsia; 2022 Sep; 63(9):2359-2370. PubMed ID: 35775943
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autistic regression associated with seizure onset in an infant with tuberous sclerosis.
    Humphrey A; Neville BG; Clarke A; Bolton PF
    Dev Med Child Neurol; 2006 Jul; 48(7):609-11. PubMed ID: 16780633
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Electrocorticographic evidence of perituberal cortex epileptogenicity in tuberous sclerosis complex.
    Ma TS; Elliott RE; Ruppe V; Devinsky O; Kuzniecky R; Weiner HL; Carlson C
    J Neurosurg Pediatr; 2012 Nov; 10(5):376-82. PubMed ID: 22998031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Efficacy of vigabatrin therapy for tuberous sclerosis with infantile spasms].
    Suzuki-Muromoto, S; Uematsu M; Sato H; Numata-Uematsu Y; Nakayama T; Kiluchi A; Kobayashi T; Hino-Fukuyo N; Kure S
    No To Hattatsu; 2016 Nov; 48(6):413-9. PubMed ID: 30010289
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cognitive impairment in tuberous sclerosis complex is a multifactorial condition.
    Jansen FE; Vincken KL; Algra A; Anbeek P; Braams O; Nellist M; Zonnenberg BA; Jennekens-Schinkel A; van den Ouweland A; Halley D; van Huffelen AC; van Nieuwenhuizen O
    Neurology; 2008 Mar; 70(12):916-23. PubMed ID: 18032744
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Update on Drug Management of Refractory Epilepsy in Tuberous Sclerosis Complex.
    van der Poest Clement E; Jansen FE; Braun KPJ; Peters JM
    Paediatr Drugs; 2020 Feb; 22(1):73-84. PubMed ID: 31912454
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
    Kotulska K; Chmielewski D; Borkowska J; Jurkiewicz E; Kuczyński D; Kmieć T; Łojszczyk B; Dunin-Wąsowicz D; Jóźwiak S
    Eur J Paediatr Neurol; 2013 Sep; 17(5):479-85. PubMed ID: 23567018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Everolimus in infants with tuberous sclerosis complex-related West syndrome: First results from a single-center prospective observational study.
    Samueli S; Dressler A; Gröppel G; Scholl T; Feucht M
    Epilepsia; 2018 Sep; 59(9):e142-e146. PubMed ID: 30098008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early control of seizures improves long-term outcome in children with tuberous sclerosis complex.
    Bombardieri R; Pinci M; Moavero R; Cerminara C; Curatolo P
    Eur J Paediatr Neurol; 2010 Mar; 14(2):146-9. PubMed ID: 19369101
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epilepsy Severity Is Associated With Head Circumference and Growth Rate in Infants With Tuberous Sclerosis Complex.
    Levine A; Davis P; Zhang B; Peters J; Filip-Dhima R; Warfield SK; Prohl A; Capal J; Krueger D; Bebin EM; Northrup H; Wu JY; Sahin M;
    Pediatr Neurol; 2023 Jul; 144():26-32. PubMed ID: 37119787
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term outcomes of resective epilepsy surgery after invasive presurgical evaluation in children with tuberous sclerosis complex and bilateral multiple lesions.
    Arya R; Tenney JR; Horn PS; Greiner HM; Holland KD; Leach JL; Gelfand MJ; Rozhkov L; Fujiwara H; Rose DF; Franz DN; Mangano FT
    J Neurosurg Pediatr; 2015 Jan; 15(1):26-33. PubMed ID: 25360852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Study on concordance of ictal and interictal epileptiform activity in patients with tuberous sclerosis complex].
    Yang Z; Guo Q; Zhuang J; Liu X; Xiong H; Wu Y; Wang S; Chang X; Zhang Y; Bao X; Jiang Y; Qin J
    Zhonghua Er Ke Za Zhi; 2014 Apr; 52(4):292-7. PubMed ID: 24915918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacotherapy for Seizures in Tuberous Sclerosis Complex.
    Nabbout R; Kuchenbuch M; Chiron C; Curatolo P
    CNS Drugs; 2021 Sep; 35(9):965-983. PubMed ID: 34417984
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Therapeutic possibilities in refractory epilepsy in tuberous sclerosis complex].
    Puertas-Martin V; Carreras-Saez I; Marana A; Ruiz-Falco Rojas ML; Cantarin-Extremera V; Calleja-Gero ML
    Rev Neurol; 2014 Jun; 58(12):529-35. PubMed ID: 24915028
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prescription patterns of antiseizure drugs in tuberous sclerosis complex (TSC)-associated epilepsy: a multicenter cohort study from Germany and review of the literature.
    Strzelczyk A; Grau J; Bast T; Bertsche A; Bettendorf U; Hahn A; Hartmann H; Hertzberg C; Hornemann F; Immisch I; Jacobs J; Klotz KA; Kluger G; Knake S; Knuf M; Kurlemann G; Marquard K; Mayer T; Meyer S; Muhle H; Müller-Schlüter K; von Podewils F; Rosenow F; Ruf S; Sauter M; Schäfer H; Schlump JU; Schubert-Bast S; Syrbe S; Thiels C; Trollmann R; Wiemer-Kruel A; Wilken B; Zukunft B; Zöllner JP
    Expert Rev Clin Pharmacol; 2021 Jun; 14(6):749-760. PubMed ID: 33792454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.